Strana 1 od 61 výsledky
FIELD OF THE INVENTION
The present invention relates to polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation. More specifically, the present invention is concerned with use of polysaccharide compositions comprising fucans and galactans
This invention relates to compounds having anti-metastatic and/or anti-inflammatory activity, and in particular it relates to the use of these compounds as anti-metastatic and/or anti-inflammatory agents in animals and man.
One of the key events in inflammation and tumour metastasis is the adherence
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of Korean Patent Application No. 10-2009-102325, filed on Oct. 27, 2009 in the Korean Intellectual Property Office, which is incorporated herein by reference in its entirety.
BACKGROUND OF THE INVENTION
(a) Field of the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the field of immunology, and more particularly to immunomodulation. The present invention provides novel compounds and methods for immunological intervention in disease states by employing synthetic polysaccharide
FIELD OF THE INVENTION
The present invention relates to compositions comprising sulfated polysaccharides and uses thereof.
BACKGROUND OF THE INVENTION
According to the world health organization (WHO), reproductive and sexual ill-health accounts for 20% of the global sickness in women and therefore
The present invention relates to aerosol compositions containing a carrier agent capable agent capable of recognizing and binding to inflammatory and tumor foci mobilizing macrophages in their immediate environment, and an aerosol substrate.
More especially, the present invention relates to aerosol
This invention relates to phosphosugars and phosphosugar containing compounds that possess anti-inflammatory and/or immunosuppressive activity, and in particular it relates to the use of these compounds as anti-inflammatory and/or immunosuppressive agents in animals and man.
BRIEF DESCRIPTION OF THE
This application is a U.S. national stage of PCT/EP2011/058334 filed on May 23, 2011, which claims priority to and the benefit of Italian Application No. MI2010A000934, filed on May 24, 2010, the contents of which are incorporated herein by reference.
TECHNICAL FIELD OF THE INVENTION
The present
TECHNICAL FIELD
This invention relates to an anti-inflammatory agent or the like having a new action mechanism. More specifically, this invention relates to a use for treatment or prophylaxis of inflammation, etc. of a sulfated acid mucopolysaccharide or sulfated dextran screened based on a new
TECHNICAL FIELD
The present invention relates to a chondroitin sulfate (CS) with an extremely low and narrowly distributed molecular weight (1000-5000 daltons, polydispersity ranging from 1.1 to 1.3) produced by chemical sulfation of an unsulfated chondroitin backbone obtained with biotechnology
The present invention relates to use of chitosan, a chitosan derivative or a physiologically acceptable salt thereof, for the preparation of a medicament, or a medical device, or a sanitary product, or a cosmetic, in form of a nail lacquer, useful for the topical treatment of inflammatory diseases
BACKGROUND OF THE INVENTION
The present invention relates to use of chitosan, a chit an derivative or a physiologically acceptable salt thereof, for the preparation of a medicament, or a medical device, or a sanitary product, or a cosmetic, in form of a nail lacquer, useful for the topical treatment
TECHNICAL FIELD OF THE INVENTION
The present disclosure relates to compositions and methods for preventing or treating inflammatory responses. Specifically the invention relates to anti-inflammatory compositions isolated from Hirsutella sinensis mycelia.
BACKGROUND OF THE INVENTION
Sepsis is a
FIELD OF THE INVENTION
The invention relates to a composition comprising a polysaccharide obtainable from the microalgae, Prasinococcus capsulatus and strains related to P. capsulatus for use prophylactically and/or therapeutically in the treatment of disorders of the immune system, such as
FIELD OF THE INVENTION
The invention relates to a composition comprising a polysaccharide obtainable from the microalgae, Prasinococcus capsulatus and strains related to P. capsulatus for use prophylactically and/or therapeutically in the treatment of disorders of the immune system, such as